Evidence map›Paper›PMID 41660590›Full record

ArticleKidney international reports2026

Long-Term Outcomes of IgM-Positive Plasma Cell Tubulointerstitial Nephritis.

Naoki Takahashi, Haruyoshi Yoshida, Hideki Kimura, Chie Yamamoto, Makoto Yamamoto, Nanami Iwamura, Kohei Matsuta, Sho Nishikawa, Kazuhisa Nishimori, Sachiko Fukushima and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Naoki TakahashiDepartment of Clinical Laboratories, University of Fukui Hospital, Fukui, Japan.
Haruyoshi YoshidaDepartment of Internal Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Fukui, Japan.
Hideki KimuraDepartment of Clinical Laboratories, University of Fukui Hospital, Fukui, Japan.
Chie YamamotoDepartment of Nephrology, Fukui General Clinic, Fukui, Japan.
Makoto YamamotoDepartment of Internal Medicine, Fukui Kosei Hospital, Fukui, Japan.
Nanami IwamuraDepartment of Clinical Laboratories, University of Fukui Hospital, Fukui, Japan.
Kohei MatsutaDepartment of Clinical Laboratories, University of Fukui Hospital, Fukui, Japan.
Sho NishikawaDepartment of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Kazuhisa NishimoriDepartment of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Sachiko FukushimaDepartment of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Yudai NishikawaDepartment of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Mamiko KobayashiDepartment of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Kenji KasunoDepartment of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Hironobu NaikiDepartment of Molecular Pathology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Masayuki IwanoDepartment of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Tadashi ToyamaDepartment of Clinical Laboratories, University of Fukui Hospital, Fukui, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IgM-positive plasma cellsimmunosuppressive therapynephrolithiasisrenal function declinetubulointerstitial nephritis

Identifiers

PMID41660590
PMCPMC12877795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.